Executing Biologics Technology Transfer through Integrated Operating Models
As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion.
As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion.
A panel at the WSGR Medical Device Conference in San Francisco delved into the specifics around what oftentimes sinks the relationship between companies and colleges and how to create real alignment and understanding between the two stakeholders.
The big data movement is redefining the way we approach biotech - and it's become an opportune destination for engineers and mathematicians.
The NIH's Neuro Challenge just announced 13 winners - student teams that built business plans around commercializing already-existing NIH technology.
Here’s another tech to file in the “boundless possibility of 3D printing” category: Two Swiss engineering professors are developing microscopic robots that will work inside the body to transport cargo – namely, drugs. Work done at ETH Zurich by Bradley Nelson, a professor of robotics and intelligent systems, and Christofer Hierold, a professor of micro […]
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences. Only 5.8% of the student population is enrolled in the Pharmacy, Nursing and Health Sciences programs at Purdue University, but healthcare startups make up half of the university’s new Startup Class of 2014. Twelve […]
Academic researchers, by nature, pursue scientifically interesting discoveries that could have a long-term impact. Meanwhile, investors and companies are interested in technologies that fill a very clear and immediate need in a market. That difference in perspective is one thing that makes translating discoveries at academic institutions into viable products so challenging, as I learned […]
In the same way that funding for early-stage innovations is changing, so is how those innovations are translated from the bench to the bedside. “Our office, which was formerly a traditional tech transfer office, has very much become a business office,” said Gary Sclar from the Dana-Farber Cancer Institute’s Office of Research and Technology Ventures. […]
Gary Fingerhut took over the commercialization arm of the Cleveland Clinic in April when former executive director Chris Coburn stepped down to take a similar position at Partners HealthCare in Boston. And apparently Fingerhut’s done a good job, as Cleveland Clinic Innovations said today that the “acting” piece of his title will be scratched, making […]
Arizona State University announced Mayo Clinic will join the Arizona Furnace and will amp up access to healthcare technology in the state’s unique startup accelerator. The accelerator supports startups in the physical and life sciences. “The AZ Furnace Program represents an opportunity to fuel innovation alongside our strategic partner, Arizona State University, as well as […]
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
A piece in Forbes this week calls attention to a recent trend in technology commercialization at universities: the use of crowdfunding. The article focused on a collaboration between the University of Utah’s Technology Commercialization Office and the crowdfunding site RocketHub, which resulted in the University Tech Vault, a portal specifically for projects that come out […]
University research and pharmaceutical employees need to replace distrust and disdain with collaboration if Indiana is to preserve and expand its place in the top tier of life sciences communities. Eli Lilly CEO Dr. John Lechleiter stressed culture change in a presentation Tuesday in Indianapolis.